81
Views
144
CrossRef citations to date
0
Altmetric
Article

TAZ Promotes PC2 Degradation through a SCFβ-Trcp E3 Ligase Complex

, , , , , , , , & show all
Pages 6383-6395 | Received 12 Feb 2007, Accepted 22 Jun 2007, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Ru-Feng Wu, Chengxu Liao, Guosheng Fu, Heather N. Hayenga, Kejia Yang, Zhenyi Ma, Zhe Liu & Lance S. Terada. (2016) p66Shc Couples Mechanical Signals to RhoA through Focal Adhesion Kinase-Dependent Recruitment of p115-RhoGEF and GEF-H1. Molecular and Cellular Biology 36:22, pages 2824-2837.
Read now
Ajaybabu V. Pobbati & Wanjin Hong. (2013) Emerging roles of TEAD transcription factors and its coactivators in cancers. Cancer Biology & Therapy 14:5, pages 390-398.
Read now
Eun Jung Jang, Hana Jeong, Ki Hwan Han, Hyug Moo Kwon, Jeong-Ho Hong & Eun Sook Hwang. (2012) TAZ Suppresses NFAT5 Activity through Tyrosine Phosphorylation. Molecular and Cellular Biology 32:24, pages 4925-4932.
Read now
Nuo Yang, Carl D. Morrison, Peijun Liu, Jeff Miecznikowski, Wiam Bshara, Suxia Han, Qing Zhu, Angela R. Omilian, Xu Li & Jianmin Zhang. (2012) TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin. Cell Cycle 11:15, pages 2922-2930.
Read now
Weirong Xing, Jonghyun Kim, Jon Wergedal, Shin-Tai Chen & Subburaman Mohan. (2010) Ephrin B1 Regulates Bone Marrow Stromal Cell Differentiation and Bone Formation by Influencing TAZ Transactivation via Complex Formation with NHERF1. Molecular and Cellular Biology 30:3, pages 711-721.
Read now
Hong Soon Kang, Ju Youn Beak, Yong-Sik Kim, Ronald Herbert & Anton M. Jetten. (2009) Glis3 Is Associated with Primary Cilia and Wwtr1/TAZ and Implicated in Polycystic Kidney Disease. Molecular and Cellular Biology 29:10, pages 2556-2569.
Read now
Qun-Ying Lei, Heng Zhang, Bin Zhao, Zheng-Yu Zha, Feng Bai, Xin-Hai Pei, Shimin Zhao, Yue Xiong & Kun-Liang Guan. (2008) TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway. Molecular and Cellular Biology 28:7, pages 2426-2436.
Read now

Articles from other publishers (137)

Brian C. Leonard, Sangwan Park, Soohyun Kim, Laura J. Young, Iman Jalilian, Krista Cosert, Xunzhi Zhang, Jessica M. Skeie, Hanna Shevalye, Nayeli Echeverria, Vanessa Rozo, Xin Gong, Chao Xing, Christopher J. Murphy, Mark A. Greiner, V. Vinod Mootha, Vijay Krishna Raghunathan & Sara M. Thomasy. (2023) Mice Deficient in TAZ (Wwtr1) Demonstrate Clinical Features of Late-Onset Fuchs’ Endothelial Corneal Dystrophy. Investigative Opthalmology & Visual Science 64:4, pages 22.
Crossref
Chao Tang, Jirong Wang, Minli Yao, Xing Ji, Wei Shi, Chengyun Xu, Ling-Hui Zeng & Ximei Wu. (2023) Hippo signaling activates hedgehog signaling by Taz-driven Gli3 processing. Cell Regeneration 12:1.
Crossref
Ying Ren, Xiaodan Zhu, Kequan Fu, Haoran Zhang, Wenchao Zhao, Yang Lin, Qian Fang, Junqi Wang, Yupeng Chen & Dong Guo. (2023) Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease. Biochemical Pharmacology 207, pages 115355.
Crossref
Sirio Dupont & Sara A. Wickström. (2022) Mechanical regulation of chromatin and transcription. Nature Reviews Genetics 23:10, pages 624-643.
Crossref
Liang Wang, Yahui Lu, Guanhui Cai, Hongyu Chen, Gen Li, Luwei Liu, Lian Sun, Zhaolan Guan, Wen Sun, Chunyang Zhao & Hua Wang. (2022) Polycystin-2 mediates mechanical tension-induced osteogenic differentiation of human adipose-derived stem cells by activating transcriptional co-activator with PDZ-binding motif. Frontiers in Physiology 13.
Crossref
Yang Li, Shu-ting Yang & Shuying Yang. (2022) Trp53 controls chondrogenesis and endochondral ossification by negative regulation of TAZ activity and stability via β-TrCP-mediated ubiquitination. Cell Death Discovery 8:1.
Crossref
Wu Jianwei, Tian Ye, Wang Hongwei, Li Dachuan, Zou Fei, Jiang Jianyuan & Wang Hongli. (2022) The Role of TAK1 in RANKL-Induced Osteoclastogenesis. Calcified Tissue International 111:1, pages 1-12.
Crossref
Jianchun Chen, Xiaoyong Wang, Qian He & Raymond C. Harris. (2022) TAZ is important for maintenance of the integrity of podocytes. American Journal of Physiology-Renal Physiology 322:4, pages F419-F428.
Crossref
Celia Fernández-MéndezPilar Santisteban. (2022) A Critical Balance Between PAX8 and the Hippo Mediator TAZ Determines Sodium/Iodide Symporter Expression and Function. Thyroid 32:3, pages 315-325.
Crossref
Carmen Berghaus, Ann-Christin Groh, Davorka Breljak, Giuliano Ciarimboli, Ivan Sabolić, Hermann Pavenstädt & Thomas Weide. (2022) Impact of Pals1 on Expression and Localization of Transporters Belonging to the Solute Carrier Family. Frontiers in Molecular Biosciences 9.
Crossref
Shabarni Gupta, Justyna E. Ozimek-Kulik & Jacqueline Kathleen Phillips. (2021) Nephronophthisis-Pathobiology and Molecular Pathogenesis of a Rare Kidney Genetic Disease. Genes 12:11, pages 1762.
Crossref
Hasegawa Takashi, Sugihara Takaaki, Hoshino Yoshiki, Tarumoto Ryohei, Matsuki Yukako, Kanda Tsutomu, Takata Tomoaki, Nagahara Takakazu, Matono Tomomitsu & Isomoto Hajime. (2021) Photosensitizer verteporfin inhibits the growth of YAP‑ and TAZ‑dominant gastric cancer cells by suppressing the anti‑apoptotic protein Survivin in a light‑independent manner. Oncology Letters 22:4.
Crossref
Cecilia Savorani, Matteo Malinverno, Roberta Seccia, Claudio Maderna, Monica Giannotta, Linda Terreran, Eleonora Mastrapasqua, Stefano Campaner, Elisabetta Dejana & Costanza Giampietro. (2021) A dual role of YAP in driving TGFβ-mediated endothelial-to-mesenchymal transition. Journal of Cell Science 134:15.
Crossref
Hiromitsu Hayashi, Norio Uemura, Liu Zhao, Kazuki Matsumura, Hiroki Sato, Yuta Shiraishi & Hideo Baba. (2021) Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 11.
Crossref
Wanlei Yang, Xuanyuan Lu, Tan Zhang, Weiqi Han, Jianlei Li, Wei He, Yewei Jia, Kangxian Zhao, An Qin & Yu Qian. (2021) TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling. Bone Research 9:1.
Crossref
Shun Saito, Shota Yamamura, Nanami Kohri, Hanako Bai, Masashi Takahashi & Manabu Kawahara. (2021) Requirement for expression of WW domain containing transcription regulator 1 in bovine trophectoderm development. Biochemical and Biophysical Research Communications 555, pages 140-146.
Crossref
Lucy LeBlanc, Nereida Ramirez & Jonghwan Kim. (2021) Context-dependent roles of YAP/TAZ in stem cell fates and cancer. Cellular and Molecular Life Sciences 78:9, pages 4201-4219.
Crossref
Jasmeet Kaur Virdi & Prasad Pethe. (2020) Biomaterials Regulate Mechanosensors YAP/TAZ in Stem Cell Growth and Differentiation. Tissue Engineering and Regenerative Medicine 18:2, pages 199-215.
Crossref
Mi Gyeong Jeong, Hyo Kyeong Kim & Eun Sook Hwang. (2021) The essential role of TAZ in normal tissue homeostasis. Archives of Pharmacal Research 44:3, pages 253-262.
Crossref
Yuhao Gao, Xiaosong ChenQing HeRyan C. GimpleYajin LiaoLiang WangRong WuQi XieJeremy N. Rich, Kunwei Shen & Zengqiang Yuan. (2020) Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin. Proceedings of the National Academy of Sciences 117:52, pages 33295-33304.
Crossref
Chiara Formica, Sandra Kunnen, Johannes G. Dauwerse, Adam E. Mullick, Kyra L. Dijkstra, Marion Scharpfenecker & Dorien J. M. Peters. (2020) Reducing YAP expression in Pkd1 mutant mice does not improve the cystic phenotype . Journal of Cellular and Molecular Medicine 24:15, pages 8876-8882.
Crossref
Andrew Streets & Albert Ong. (2020) Post-translational modifications of the polycystin proteins. Cellular Signalling 72, pages 109644.
Crossref
Almira Kurbegovic & Marie Trudel. (2020) The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease. Cellular Signalling 71, pages 109594.
Crossref
Roman-Ulrich Müller & Bernhard Schermer. (2019) Hippo signaling—a central player in cystic kidney disease?. Pediatric Nephrology 35:7, pages 1143-1152.
Crossref
Heinrich Kovar, Lisa Bierbaumer & Branka Radic-Sarikas. (2020) The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis. Cells 9:4, pages 972.
Crossref
Tianyanxin Sun & Francisco J. Diaz. (2019) Ovulatory signals alter granulosa cell behavior through YAP1 signaling. Reproductive Biology and Endocrinology 17:1.
Crossref
Zhaohui Yang & Alexandra L. Joyner. (2019) YAP1 is involved in replenishment of granule cell precursors following injury to the neonatal cerebellum. Developmental Biology 455:2, pages 458-472.
Crossref
Catherine Meyer-Schwesinger. (2019) The ubiquitin–proteasome system in kidney physiology and disease. Nature Reviews Nephrology 15:7, pages 393-411.
Crossref
Cho-Long Kim, Sue-Hee Choi & Jung-Soon Mo. (2019) Role of the Hippo Pathway in Fibrosis and Cancer. Cells 8:5, pages 468.
Crossref
Emily J Lodge, Alice Santambrogio, John P Russell, Paraskevi Xekouki, Thomas S Jacques, Randy L Johnson, Selvam Thavaraj, Stefan R Bornstein & Cynthia Lilian Andoniadou. (2019) Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade. eLife 8.
Crossref
Akihiro Matsushita, Tatsuhiro Sato, Satomi Mukai, Teruaki Fujishita, Emi Mishiro-Sato, Maho Okuda, Masahiro Aoki, Yoshinori Hasegawa & Yoshitaka Sekido. (2018) TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation. Oncogene 38:11, pages 1966-1978.
Crossref
Bernard A. Callus, Megan L. Finch‐Edmondson, Sue Fletcher & Steve D. Wilton. (2019) YAP ping about and not forgetting TAZ . FEBS Letters 593:3, pages 253-276.
Crossref
Qing He, Yuhao Gao, Tongxing Wang, Lujun Zhou, Wenxia Zhou & Zengqiang Yuan. (2019) Deficiency of Yes-Associated Protein Induces Cataract in Mice. Aging and disease 10:2, pages 293.
Crossref
David Merrick, Kavita Mistry, Jingshing Wu, Nikolay Gresko, Julie E Baggs, John B Hogenesch, Zhaoxia Sun & Michael J Caplan. (2019) Polycystin-1 regulates bone development through an interaction with the transcriptional coactivator TAZ. Human Molecular Genetics 28:1, pages 16-30.
Crossref
Keiichiro Kamura, Jihoon Shin, Hiroshi Kiyonari, Takaya Abe, Go Shioi, Atsunori Fukuhara & Hiroshi Sasaki. (2018) Obesity in Yap transgenic mice is associated with TAZ downregulation. Biochemical and Biophysical Research Communications 505:3, pages 951-957.
Crossref
Amir Kedan, Nandini Verma, Ashish Saroha, Michal Shreberk-Shaked, Anna-Katharina Müller, Nishanth Ulhas Nair & Sima Lev. (2018) PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein. Cell Death & Disease 9:10.
Crossref
Jianchun ChenHuaizhou You, Yan Li, You Xu, Qian He & Raymond C. Harris. (2018) EGF Receptor–Dependent YAP Activation Is Important for Renal Recovery from AKI. Journal of the American Society of Nephrology 29:9, pages 2372-2385.
Crossref
Xiaogui Yi, Jia Yu, Chao Ma, Li Li, Lingfei Luo, Hongtao Li, Hua Ruan & Honghui Huang. (2018) Yap1/Taz are essential for the liver development in zebrafish. Biochemical and Biophysical Research Communications 503:1, pages 131-137.
Crossref
Steven W. Plouffe, Kimberly C. Lin, Jerrell L. Moore3rd3rd, Frederick E. Tan, Shenghong Ma, Zhen Ye, Yunjiang Qiu, Bing Ren & Kun-Liang Guan. (2018) The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell. Journal of Biological Chemistry 293:28, pages 11230-11240.
Crossref
Jinhu Xiong, Maria Almeida & Charles A. O'Brien. (2018) The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation. Bone 112, pages 1-9.
Crossref
Marcello Maugeri-Saccà & Ruggero De Maria. (2018) The Hippo pathway in normal development and cancer. Pharmacology & Therapeutics 186, pages 60-72.
Crossref
Wanlei Yang, Weiqi Han, An Qin, Ziyi Wang, Jiake Xu & Yu Qian. (2018) The emerging role of Hippo signaling pathway in regulating osteoclast formation. Journal of Cellular Physiology 233:6, pages 4606-4617.
Crossref
Erika Ishihara & Hiroshi Nishina. (2018) The Hippo-YAP Pathway Regulates 3D Organ Formation and Homeostasis. Cancers 10:4, pages 122.
Crossref
Sean Porazinski & Michael Ladomery. (2018) Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets. Genes 9:3, pages 161.
Crossref
Zhousheng Xiao, Jerome Baudry, Li Cao, Jinsong Huang, Hao Chen, Charles R. Yates, Wei Li, Brittany Dong, Christopher M. Waters, Jeremy C. Smith & L. Darryl Quarles. (2017) Polycystin-1 interacts with TAZ to stimulate osteoblastogenesis and inhibit adipogenesis. Journal of Clinical Investigation 128:1, pages 157-174.
Crossref
Mi Gyeong Jeong, Hyuna Song, Ji Hyun Shin, Hana Jeong, Hyo Kyeong Kim & Eun Sook Hwang. (2017) Transcriptional coactivator with PDZ-binding motif is required to sustain testicular function on aging. Aging Cell 16:5, pages 1035-1042.
Crossref
U. Michgehl, H. Pavenstädt & B. Vollenbröker. (2017) Cross talk between the Crumbs complex and Hippo signaling in renal epithelial cells. Pflügers Archiv - European Journal of Physiology 469:7-8, pages 917-926.
Crossref
Congshan Sun, Vanessa De Mello, Abdalla Mohamed, Huascar P. Ortuste Quiroga, Amaya Garcia-Munoz, Abdullah Al Bloshi, Annie M. Tremblay, Alexander von Kriegsheim, Elaina Collie-Duguid, Neil Vargesson, David Matallanas, Henning Wackerhage & Peter S. Zammit. (2017) Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function. Stem Cells 35:8, pages 1958-1972.
Crossref
Thomas Weide, Beate Vollenbröker, Ulf Schulze, Ivona Djuric, Maria Edeling, Jakob Bonse, Florian Hochapfel, Olga Panichkina, Dirk-Oliver Wennmann, Britta George, Seonhee Kim, Christoph Daniel, Jochen Seggewiß, Kerstin Amann, Wilhelm Kriz, Michael P. Krahn & Hermann Pavenstädt. (2017) Pals1 Haploinsufficiency Results in Proteinuria and Cyst Formation. Journal of the American Society of Nephrology 28:7, pages 2093-2107.
Crossref
Markus M. Rinschen, Florian GrahammerAnn-Kathrin Hoppe, Priyanka KohliHenning Hagmann, Oliver KretzSabine BertschMartin Höhne, Heike GöbelMalte P. BartramRajesh Kumar GandhirajanMarcus KrügerPaul-Thomas BrinkkoetterTobias B. HuberMartin KannSara A. Wickström, Thomas Benzing & Bernhard Schermer. (2017) YAP-mediated mechanotransduction determines the podocyte’s response to damage. Science Signaling 10:474.
Crossref
Miki Nishio, Tomohiko Maehama, Hiroki Goto, Keisuke Nakatani, Wakako Kato, Hirofumi Omori, Yosuke Miyachi, Hideru Togashi, Yohei Shimono & Akira Suzuki. (2017) Hippo vs. Crab: tissue-specific functions of the mammalian Hippo pathway. Genes to Cells 22:1, pages 6-31.
Crossref
Richard W. Naylor, Sarah S. Qubisi & Alan J. Davidson. 2017. Kidney Development and Disease. Kidney Development and Disease 27 53 .
Julian Kwan, Anna Sczaniecka, Emad Heidary Arash, Liem Nguyen, Chia-Chun Chen, Srdjana Ratkovic, Olga Klezovitch, Liliana Attisano, Helen McNeill, Andrew Emili & Valeri Vasioukhin. (2016) DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2. Genes & Development 30:24, pages 2696-2709.
Crossref
Shu-Ping Wang & Lan-Hsin Wang. (2016) Disease implication of hyper-Hippo signalling. Open Biology 6:10, pages 160119.
Crossref
Xin Zhou & Qun-Ying Lei. (2016) Regulation of TAZ in cancer. Protein & Cell 7:8, pages 548-561.
Crossref
Mami Uemura, Ayumi Nagasawa & Kenta Terai. (2016) Yap/Taz transcriptional activity in endothelial cells promotes intramembranous ossification via the BMP pathway. Scientific Reports 6:1.
Crossref
Rajesh Kumar Gandhirajan, Manaswita Jain, Benedikt Walla, Marc Johnsen, Malte P. Bartram, Minh Huynh Anh, Markus M. Rinschen, Thomas Benzing & Bernhard Schermer. (2016) Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ). Journal of Biological Chemistry 291:22, pages 11596-11607.
Crossref
Carlo Spirli, Ambra Villani, Valeria Mariotti, Luca Fabris, Romina Fiorotto & Mario Strazzabosco. (2015) Retracted: Posttranslational regulation of polycystin‐2 protein expression as a novel mechanism of cholangiocyte reaction and repair from biliary damage. Hepatology 62:6, pages 1828-1839.
Crossref
Marie Trudel. 2015. Polycystic Kidney Disease. Polycystic Kidney Disease 231 257 .
Andrea Pappalardo, Immacolata Porreca, Luigi Caputi, Elena De Felice, Stephan Schulte-Merker, Mariastella Zannini & Paolo Sordino. (2015) Thyroid development in zebrafish lacking Taz. Mechanisms of Development 138, pages 268-278.
Crossref
Jiaojiao Zhang, Shipeng Yuan, Aleksandr Vasilyev & M. Amin Arnaout. (2015) The transcriptional coactivator Taz regulates proximodistal patterning of the pronephric tubule in zebrafish. Mechanisms of Development 138, pages 328-335.
Crossref
Fa-Xing Yu, Bin Zhao & Kun-Liang Guan. (2015) Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell 163:4, pages 811-828.
Crossref
Albert C.M. Ong & Peter C. Harris. (2015) A polycystin-centric view of cyst formation and disease: the polycystins revisited. Kidney International 88:4, pages 699-710.
Crossref
Yulei Zhao & Xiaolong Yang. (2015) Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling. Oncotarget 6:26, pages 21906-21917.
Crossref
Tianyanxin Sun, Melissa E. Pepling & Francisco J. Diaz. (2015) Lats1 Deletion Causes Increased Germ Cell Apoptosis and Follicular Cysts in Mouse Ovaries1. Biology of Reproduction 93:1.
Crossref
G Liu, F-X Yu, Y C Kim, Z Meng, J Naipauer, D J Looney, X Liu, J S Gutkind, E A Mesri & K-L Guan. (2014) Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. Oncogene 34:27, pages 3536-3546.
Crossref
Zhousheng Xiao & Leigh Darryl Quarles. (2015) Physiological mechanisms and therapeutic potential of bone mechanosensing. Reviews in Endocrine and Metabolic Disorders 16:2, pages 115-129.
Crossref
Qian Wang, Wang Zheng, Zuocheng Wang, JungWoo Yang, Shaimaa Hussein, Jingfeng Tang & Xing-Zhen Chen. (2015) Filamin-A Increases the Stability and Plasma Membrane Expression of Polycystin-2. PLOS ONE 10:4, pages e0123018.
Crossref
Jongshin Kim, Haiin Jo, Hyowon Hong, Min Hwan Kim, Jin Man Kim, June-Koo Lee, Won Do Heo & Joon Kim. (2015) Actin remodelling factors control ciliogenesis by regulating YAP/TAZ activity and vesicle trafficking. Nature Communications 6:1.
Crossref
Steven W. Plouffe, Audrey W. Hong & Kun-Liang Guan. (2015) Disease implications of the Hippo/YAP pathway. Trends in Molecular Medicine 21:4, pages 212-222.
Crossref
Yaopan Mao, Philippa Francis-West & Kenneth D. Irvine. (2015) A Fat4-Dchs1 signal between stromal and cap mesenchyme cells influences nephrogenesis and ureteric bud branching. Development.
Crossref
Miki Nishio, Hiroki Goto, Miki Suzuki, Aya Fujimoto, Koshi Mimori & Akira Suzuki. 2015. Innovative Medicine. Innovative Medicine 79 94 .
Emad Heidary Arash, Ki Myung Song, Siyuan Song, Ahmed Shiban & Liliana Attisano. (2014) Arhgef7 promotes activation of the Hippo pathway core kinase Lats. The EMBO Journal 33:24, pages 2997-3011.
Crossref
Zhousheng Xiao, Li Cao, Yingjuan Liang, Jinsong Huang, Amber Rath Stern, Mark Dallas, Mark Johnson & Leigh Darryl Quarles. (2014) Osteoblast-Specific Deletion of Pkd2 Leads to Low-Turnover Osteopenia and Reduced Bone Marrow Adiposity. PLoS ONE 9:12, pages e114198.
Crossref
Renée M. Robbins, Samantha C. Gbur & Greg J. Beitel. (2014) Non-Canonical Roles for Yorkie and Drosophila Inhibitor of Apoptosis 1 in Epithelial Tube Size Control. PLoS ONE 9:7, pages e101609.
Crossref
M R Byun, J-H Hwang, A R Kim, K M Kim, E S Hwang, M B Yaffe & J-H Hong. (2014) Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation. Cell Death & Differentiation 21:6, pages 854-863.
Crossref
Xaralabos Varelas. (2014) The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development 141:8, pages 1614-1626.
Crossref
Valeriu Cebotaru, Liudmila Cebotaru, Hyunho Kim, Marco Chiaravalli, Alessandra Boletta, Feng Qian & William B. Guggino. (2014) Polycystin-1 Negatively Regulates Polycystin-2 Expression via the Aggresome/Autophagosome Pathway. Journal of Biological Chemistry 289:10, pages 6404-6414.
Crossref
Adam Skibinski, Jerrica L. Breindel, Aleix Prat, Patricia Galván, Elizabeth Smith, Andreas Rolfs, Piyush B. Gupta, Joshua LaBaer & Charlotte Kuperwasser. (2014) The Hippo Transducer TAZ Interacts with the SWI/SNF Complex to Regulate Breast Epithelial Lineage Commitment. Cell Reports 6:6, pages 1059-1072.
Crossref
Min-Jung Lee, Mi Ran Byun, Makoto Furutani-Seiki, Jeong-Ho Hong & Han-Sung Jung. (2014) YAP and TAZ Regulate Skin Wound Healing. Journal of Investigative Dermatology 134:2, pages 518-525.
Crossref
Mariam Semmo, Michael Köttgen & Alexis Hofherr. 2014. Mammalian Transient Receptor Potential (TRP) Cation Channels. Mammalian Transient Receptor Potential (TRP) Cation Channels 675 711 .
Hiroyuki Inuzuka & Wenyi WeiAlan W. Lau, Yueyong Liu, Adriana E. Tron, Hiroyuki Inuzuka & Wenyi Wei. 2014. SCF and APC E3 Ubiquitin Ligases in Tumorigenesis. SCF and APC E3 Ubiquitin Ligases in Tumorigenesis 15 45 .
Jungwoo Yang, Wang Zheng, Qian Wang, Carlos Lara, Shaimaa Hussein & Xing‐Zhen Chen. (2013) Translational up‐regulation of polycystic kidney disease protein PKD2 by endoplasmic reticulum stress. The FASEB Journal 27:12, pages 4998-5009.
Crossref
Valeria Lucci, Tina Di Palma, Chiara D'Ambrosio, Andrea Scaloni & Mariastella Zannini. (2013) AMOTL2 interaction with TAZ causes the inhibition of surfactant proteins expression in lung cells. Gene 529:2, pages 300-306.
Crossref
Ilenia Bernascone & Fernando Martin-Belmonte. (2013) Crossroads of Wnt and Hippo in epithelial tissues. Trends in Cell Biology 23:8, pages 380-389.
Crossref
Danielle K. Manning, Mikhail Sergeev, Roy G. van Heesbeen, Michael D. Wong, Jin-Hee Oh, Yan Liu, R. Mark Henkelman, Iain Drummond, Jagesh V. Shah & David R. Beier. (2013) Loss of the Ciliary Kinase Nek8 Causes Left-Right Asymmetry Defects. Journal of the American Society of Nephrology 24:1, pages 100-112.
Crossref
Fa-Xing Yu, Bin Zhao & Kun-Liang Guan. 2013. The Hippo Signaling Pathway and Cancer. The Hippo Signaling Pathway and Cancer 71 87 .
Xaralabos Varelas. 2013. The Hippo Signaling Pathway and Cancer. The Hippo Signaling Pathway and Cancer 327 346 .
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems 465 646 .
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems 387 463 .
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems 379 386 .
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems 311 378 .
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems 175 310 .
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems 137 173 .
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems 109 135 .
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems 7 107 .
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems 911 918 .
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems 821 909 .
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems 647 819 .
Sandra Habbig, Malte P. Bartram, Josef G. Sägmüller, Anabel Griessmann, Mareike Franke, Roman-Ulrich Müller, Ricarda Schwarz, Martin Hoehne, Carsten Bergmann, Claudia Tessmer, H. Christian Reinhardt, Volker Burst, Thomas Benzing & Bernhard Schermer. (2012) The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ. Human Molecular Genetics 21:26, pages 5528-5538.
Crossref
Wanjin Hong & Kun-Liang Guan. (2012) The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway. Seminars in Cell & Developmental Biology 23:7, pages 785-793.
Crossref
Wei Huang, Xianbo Lv, Chenying Liu, Zhengyu Zha, Heng Zhang, Ying Jiang, Yue Xiong, Qun-Ying Lei & Kun-Liang Guan. (2012) The N-terminal Phosphodegron Targets TAZ/WWTR1 Protein for SCFβ-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition. Journal of Biological Chemistry 287:31, pages 26245-26253.
Crossref
Han Qin, Kathryn Blaschke, Grace Wei, Yuki Ohi, Laure Blouin, Zhongxia Qi, Jingwei Yu, Ru-Fang Yeh, Matthias Hebrok & Miguel Ramalho-Santos. (2012) Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming. Human Molecular Genetics 21:9, pages 2054-2067.
Crossref
A Mauviel, F Nallet-Staub & X Varelas. (2011) Integrating developmental signals: a Hippo in the (path)way. Oncogene 31:14, pages 1743-1756.
Crossref
Xaralabos Varelas & Jeffrey L. Wrana. (2012) Coordinating developmental signaling: novel roles for the Hippo pathway. Trends in Cell Biology 22:2, pages 88-96.
Crossref
Mi Ran Byun, Hana Jeong, Su Jung Bae, A Rum Kim, Eun Sook Hwang & Jeong-Ho Hong. (2012) TAZ is required for the osteogenic and anti-adipogenic activities of kaempferol. Bone 50:1, pages 364-372.
Crossref
Hester Happé, Emile de Heer & Dorien J.M. Peters. (2011) Polycystic kidney disease: The complexity of planar cell polarity and signaling during tissue regeneration and cyst formation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:10, pages 1249-1255.
Crossref
Z Zhou, Y Hao, N Liu, L Raptis, M-S Tsao & X Yang. (2011) TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 30:18, pages 2181-2186.
Crossref
Susan K. Dutcher & Huawen Lin. (2011) Tying TAZ and Nek1 into Polycystic Kidney Disease through Polycystin 2 Levels. Journal of the American Society of Nephrology 22:5, pages 791-793.
Crossref
Hyungshin Yim, Chang K. Sung, John You, Yu Tian & Thomas Benjamin. (2011) Nek1 and TAZ Interact to Maintain Normal Levels of Polycystin 2. Journal of the American Society of Nephrology 22:5, pages 832-837.
Crossref
Hester Happé, Annemieke M van der Wal, Wouter N Leonhard, Steven J Kunnen, Martijn H Breuning, Emile de Heer & Dorien JM Peters. (2011) Altered Hippo signalling in polycystic kidney disease. The Journal of Pathology 224:1, pages 133-142.
Crossref
Siew Wee Chan, Chun Jye Lim, Liming Chen, Yaan Fun Chong, Caixia Huang, Haiwei Song & Wanjin Hong. (2011) The hippo pathway in biological control and cancer development. Journal of Cellular Physiology 226:4, pages 928-939.
Crossref
Daniela Rotin & Olivier Staub. (2010) Role of the ubiquitin system in regulating ion transport. Pflügers Archiv - European Journal of Physiology 461:1, pages 1-21.
Crossref
Bin Zhao, Li Li & Kun-Liang Guan. (2010) Hippo signaling at a glance. Journal of Cell Science 123:23, pages 4001-4006.
Crossref
Jun Yan & Yue Xiong. (2010) Targeted Ubiquitylation: The Prey Becomes Predator. Molecular Cell 40:6, pages 853-855.
Crossref
Ikram Ouni, Karin Flick & Peter Kaiser. (2010) A Transcriptional Activator Is Part of an SCF Ubiquitin Ligase to Control Degradation of Its Cofactors. Molecular Cell 40:6, pages 954-964.
Crossref
Chen-Ying Liu, Zheng-Yu Zha, Xin Zhou, Heng Zhang, Wei Huang, Di Zhao, Tingting Li, Siew Wee Chan, Chun Jye Lim, Wanjin Hong, Shimin Zhao, Yue Xiong, Qun-Ying Lei & Kun-Liang Guan. (2010) The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase. Journal of Biological Chemistry 285:48, pages 37159-37169.
Crossref
Kerstin Duning, Deike Rosenbusch, Marc A. Schlüter, Yuemin Tian, Karl Kunzelmann, Nina Meyer, Ulf Schulze, Arseni Markoff, Hermann Pavenstädt & Thomas Weide. (2010) Polycystin-2 Activity Is Controlled by Transcriptional Coactivator with PDZ Binding Motif and PALS1-associated Tight Junction Protein. Journal of Biological Chemistry 285:44, pages 33584-33588.
Crossref
Duojia Pan. (2010) The Hippo Signaling Pathway in Development and Cancer. Developmental Cell 19:4, pages 491-505.
Crossref
Bin Zhao, Li Li, Qunying Lei & Kun-Liang Guan. (2010) The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version. Genes & Development 24:9, pages 862-874.
Crossref
Xaralabos Varelas, Bryan W. Miller, Richelle Sopko, Siyuan Song, Alex Gregorieff, Frederic A. Fellouse, Rui Sakuma, Tony Pawson, Walter Hunziker, Helen McNeill, Jeffrey L. Wrana & Liliana Attisano. (2010) The Hippo Pathway Regulates Wnt/β-Catenin Signaling. Developmental Cell 18:4, pages 579-591.
Crossref
Mei Wang, James P. Bridges, Cheng-Lun Na, Yan Xu & Timothy E. Weaver. (2009) Meckel-Gruber Syndrome Protein MKS3 Is Required for Endoplasmic Reticulum-associated Degradation of Surfactant Protein C. Journal of Biological Chemistry 284:48, pages 33377-33383.
Crossref
Michele M. Fluck & Brian S. Schaffhausen. (2009) Lessons in Signaling and Tumorigenesis from Polyomavirus Middle T Antigen. Microbiology and Molecular Biology Reviews 73:3, pages 542-563.
Crossref
Jeffrey G. DickhoutJoan C. Krepinsky. (2009) Endoplasmic Reticulum Stress and Renal Disease. Antioxidants & Redox Signaling 11:9, pages 2341-2352.
Crossref
Akihisa Mitani, Takahide Nagase, Kazunori Fukuchi, Hiroyuki Aburatani, Ryosuke Makita & Hiroki Kurihara. (2009) Transcriptional Coactivator with PDZ-binding Motif Is Essential for Normal Alveolarization in Mice. American Journal of Respiratory and Critical Care Medicine 180:4, pages 326-338.
Crossref
Dun Hong, Hai-Xiao Chen, Yun Xue, Dong-Mei Li, Xiao-Chen Wan, Renshan Ge & Ji-Cheng Li. (2009) Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells. The Journal of Steroid Biochemistry and Molecular Biology 116:1-2, pages 86-92.
Crossref
Vicente E. Torres & Peter C. Harris. (2009) Autosomal dominant polycystic kidney disease: the last 3 years. Kidney International 76:2, pages 149-168.
Crossref
Alexander Hergovich & Brian A. Hemmings. (2009) Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling. BioFactors 35:4, pages 338-345.
Crossref
Siew Wee Chan, Chun Jye Lim, Li Shen Loo, Yaan Fun Chong, Caixia Huang & Wanjin Hong. (2009) TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation. Journal of Biological Chemistry 284:21, pages 14347-14358.
Crossref
A. M. Ferrara, L. De Sanctis, G. Rossi, S. Capuano, G. Del Prete, E. Zampella, P. Gianino, A. Corrias, G. Fenzi, M. Zannini & P. E. Macchia. (2014) Mutations in TAZ/WWTR1, a co-activator of NKX2.1 and PAX8 are not a frequent cause of thyroid dysgenesis. Journal of Endocrinological Investigation 32:3, pages 238-241.
Crossref
Kainan Wang, Cindy Degerny, Minghong Xu & Xiang-Jiao Yang. (2009) YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human diseaseThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB’s 51st Annual Meeting – Epigenetics and Chromatin Dynamics, and has undergone the Journal’s usual peer review process.. Biochemistry and Cell Biology 87:1, pages 77-91.
Crossref
Brian S. Schaffhausen & Thomas M. Roberts. (2009) Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer. Virology 384:2, pages 304-316.
Crossref
Tina Di Palma, Barbara D'Andrea, Giovanna Lucia Liguori, Annamaria Liguoro, Tiziana de Cristofaro, Dolores Del Prete, Andrea Pappalardo, Anna Mascia & Mariastella Zannini. (2009) TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation. Experimental Cell Research 315:2, pages 162-175.
Crossref
Ingyu Kim, Cunxi Li, Dan Liang, Xing-Zhen Chen, Robert J. Coffy, Jie Ma, Ping Zhao & Guanqing Wu. (2008) Polycystin-2 Expression Is Regulated by a PC2-binding Domain in the Intracellular Portion of Fibrocystin. Journal of Biological Chemistry 283:46, pages 31559-31566.
Crossref
David Frescas & Michele Pagano. (2008) Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer. Nature Reviews Cancer 8:6, pages 438-449.
Crossref
Siew Wee Chan, Chun Jye Lim, Ke Guo, Chee Peng Ng, Ian Lee, Walter Hunziker, Qi Zeng & Wanjin Hong. (2008) A Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells. Cancer Research 68:8, pages 2592-2598.
Crossref
Ryosuke Makita, Yasunobu Uchijima, Koichi Nishiyama, Tomokazu Amano, Qin Chen, Takumi Takeuchi, Akihisa Mitani, Takahide Nagase, Yutaka Yatomi, Hiroyuki Aburatani, Osamu Nakagawa, Erin V. Small, Patricia Cobo-Stark, Peter Igarashi, Masao Murakami, Junji Tominaga, Takahiro Sato, Tomoichiro Asano, Yukiko Kurihara & Hiroki Kurihara. (2008) Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. American Journal of Physiology-Renal Physiology 294:3, pages F542-F553.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.